Single-Cell AML Mapping Finds Chemoresistant States
A peer-reviewed pediatric AML study integrates paired diagnosis–relapse single-cell data with larger outcome cohorts to identify rare chemoresistant cell states that improve risk stratification and nominate drug vulnerabilities. The framework is translationally credible, but…
